Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model

International Journal of Oncology

Volumn 35, Issue 4, 2009, Pages 741-749

  Okudaira, Keisuke ^a   Hokari, Ryota ^a   Tsuzuki, Yoshikazu ^a   Okada, Yoshikiyo ^a   Komoto, Shunsuke ^a   Watanabe, Chikako ^a   Kurihara, Chie ^a   Kawaguchi, Atsushi ^a   Nagao, Shigeaki ^a   Azuma, Miyuki ^b   Yagita, Hideo ^c   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokyo Medical and Dental University ^*  (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B7 H1 B7 DC; Pancreatic cancer; PD 1; Regulatory T cell

Indexed keywords

B7 DC ANTIBODY; B7 H1 ANTIBODY; BLOCKING ANTIBODY; CD11 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PANCREATIC NEOPLASMS; PEPTIDES; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 70449395259     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000387     Document Type: Article

References (43)

1. Dong H, Zhu G, Tamada K and Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5: 1365-1369, 1999.
2. Freeman GJ, Long AJ, Iwai Y, et al: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034, 2000. (Pubitemid 30765695)
3. Yoshinaga SK, Whoriskey JS, Khare SD, et al: T-cell co-stimulation through B7RP-1 and ICOS. Nature 402: 827-832, 1999. (Pubitemid 129638129)
4. Swallow MM, Wallin JJ and Sha WC: B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF-alpha. Immunity 11: 423-432, 1999.
5. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K and Chen L: B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2: 269-274, 2001. (Pubitemid 33706005)
6. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM and Tsuchiya H: B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193: 839-846, 2001. (Pubitemid 32524533)
7. Latchman Y, Wood CR, Chernova T, et al: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261-268, 2001. (Pubitemid 33706004)
8. Ishida Y, Agata Y, Shibahara K and Honjo T: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11: 3887-3895, 1992.
9. Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H and Honjo T: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8: 765-772, 1996. (Pubitemid 26148299)
10. Nishimura H and Honjo T: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 22: 265-268, 2001. (Pubitemid 32667515)
11. Carreno BM and Collins M: The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20: 29-53, 2002.
12. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M and Yagita H: Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169: 5538-5545, 2002. (Pubitemid 35291652)
13. Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K and Chen L: B7-H1 costimulation preferentially enhances CD28- independent T-helper cell function. Blood 97: 1809-1816, 2001.
14. Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH and Khoury SJ: Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 198: 71-78, 2003. (Pubitemid 36870187)
15. Liu X, Gao JX, Wen J, Yin L, Li O, Zuo T, Gajewski TF, Fu YX, Zheng P and Liu Y: B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 197: 1721-1730, 2003. (Pubitemid 36745347)
16. Strome SE, Dong H, Tamura H, et al: B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 63: 6501-6505, 2003. (Pubitemid 37255203)
17. Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R, Weller M and Wiendl H: Expression of the B7- related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res 63: 7462-7467, 2003. (Pubitemid 37413489)
18. Okazaki T, Maeda A, Nishimura H, Kurosaki T and Honjo T: PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98: 13866-13871, 2001. (Pubitemid 33115990)
19. Nishimura H, Nose M, Hiai H, Minato N and Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immuno-receptor. Immunity 11: 141-151, 1999. (Pubitemid 29428807)
20. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N and Honjo T: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319-322, 2001. (Pubitemid 32096320)
21. Iwai Y, Terawaki S and Honjo T: PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol 17: 133-144, 2005. (Pubitemid 40246578)
22. Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, Nakamura S, Enomoto K, Yagita H, Azuma M and Nakajima Y: Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 13: 2151-2157, 2007. (Pubitemid 46649885)
23. Dong H, Strome SE, Salomao DR, et al: Tumor-associated B7- H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8: 793-800, 2002. (Pubitemid 34887242)
24. Shin T, Yoshimura K, Shin T, Crafton EB, Tsuchiya H, Housseau F, Koseki H, Schulick RD, Chen L and Pardoll DM: In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med 201: 1531-1541, 2005.
25. + regulatory T cells. Semin Immunol 16: 89-98, 2004.
26. + suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389-400, 2002.
27. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS and Linehan DC: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169: 2756-2761, 2002. (Pubitemid 34921025)
28. Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P and Ferradini L: Foxp3 expressing CD4+CD25(high) regulatory T cells are over-represented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173: 1444-1453, 2004. (Pubitemid 38924326)
29. Curiel TJ, Coukos G, Zou L, et al: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949, 2004. (Pubitemid 39273735)
30. + regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann Surg Oncol 13: 1252-1258, 2006.
31. Shi D, Fu M, Fan P, Li W, Chen X, Li C, Qi X, Gao T and Liu Y: Artificial phosphatidylserine liposome mimics apoptotic cells in inhibiting maturation and immunostimulatory function of murine myeloid dendritic cells in response to 1-chloro-2,4- dinitrobenze in vitro. Arch Dermatol Res 299: 327-336, 2007. (Pubitemid 47282759)
32. Miyazaki J, Tsuzuki Y, Matsuzaki K, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K and Miura S: Combination therapy with tumor-lysate pulsed dendritic cells and anti-angiogenic drug TNP-470 for mouse pancreatic cancer. Int J Cancer 117: 499-505, 2005. (Pubitemid 41429575)
33. Okudaira K, Tsuzuki Y, Hokari R, Miyazaki J, Mataki N, Komoto S, Okada Y, Kawaguchi A, Nagao S, Itoh K and Miura S: Effects of intratumoral injection of CCL2 on monocyte-endothelial cell interactions in mouse pancreatic cancer. Microcirculation 14: 241-251, 2007. (Pubitemid 46547101)
34. + T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J Immunol 175: 1586-1592, 2005.
35. Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M, Rietz C, Flies DB, Lau JS, Zhu G, Tamada K and Chen L: Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 65: 1089-1096, 2005. (Pubitemid 40216472)
36. + T cell responses in a hepatitis C virus core murine model. J Immunol 180: 4875-4884, 2008.
37. Guiducci C, Vicari AP, Sangaletti S, Trinchieri G and Colombo MP: Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 65: 3437-3446, 2005. (Pubitemid 40524630)
38. Dieckmann D, Bruett CH, Ploettner H, Lutz MB and Schuler G: Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1- like regulatory T cells [corrected]. J Exp Med 196: 247-253, 2002. (Pubitemid 34787514)
39. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J and Enk AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 196: 255-260, 2002. (Pubitemid 34787515)
40. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 196: 1335-1346, 2002.
41. Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, Romagnani P, Maggi E and Romagnani S: Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med 196: 379-387, 2002. (Pubitemid 34879113)
42. Nakamura K, Kitani A and Strober W: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194: 629-644, 2001. (Pubitemid 32844773)
43. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H and Shevach EM: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 196: 237-246, 2002. (Pubitemid 34787513)